000			02060 a2200589 4500
005			20250513183744.0
264		0	_c19990729
008			199907s 0 0 eng d
022			_a0022-1899
024	7		_a10.1086/314834 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacobson, J M
245	0	0	_aThalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. _h[electronic resource]
260			_bThe Journal of infectious diseases _cJul 1999
300			_a61-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcquired Immunodeficiency Syndrome _xcomplications
650	0	4	_aAdult
650	0	4	_aAntigens, CD _xanalysis
650	0	4	_aDouble-Blind Method
650	0	4	_aEsophageal Diseases _xcomplications
650	0	4	_aEthnicity
650	0	4	_aFemale
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPlacebos
650	0	4	_aQuality of Life
650	0	4	_aReceptors, Tumor Necrosis Factor _xanalysis
650	0	4	_aReceptors, Tumor Necrosis Factor, Type II
650	0	4	_aStomatitis, Aphthous _xdrug therapy
650	0	4	_aThalidomide _xadverse effects
650	0	4	_aTumor Necrosis Factor-alpha _xanalysis
650	0	4	_aUlcer _xcomplications
650	0	4	_aUnited States
700	1		_aSpritzler, J
700	1		_aFox, L
700	1		_aFahey, J L
700	1		_aJackson, J B
700	1		_aChernoff, M
700	1		_aWohl, D A
700	1		_aWu, A W
700	1		_aHooton, T M
700	1		_aSha, B E
700	1		_aShikuma, C M
700	1		_aMacPhail, L A
700	1		_aSimpson, D M
700	1		_aTrapnell, C B
700	1		_aBasgoz, N
773	0		_tThe Journal of infectious diseases _gvol. 180 _gno. 1 _gp. 61-7
856	4	0	_uhttps://doi.org/10.1086/314834 _zAvailable from publisher's website
999			_c10312506 _d10312506